TY  - JOUR
AU  - Deza, Gustavo
AU  - Notario, Jaime
AU  - Ferran, Marta
AU  - Beltrán, Emma
AU  - Almirall, Miriam
AU  - Alcalá, Rebeca
AU  - Ruiz-Carrascosa, José Carlos
AU  - Sánchez, Ricardo
AU  - Pérez, Silvia
AU  - García-Vivar, María Luz
AU  - Galíndez, Eva
AU  - Mora, Maribel
AU  - Rodríguez, Jesús
AU  - Gallardo, Fernando
PY  - 2018
DO  - 10.1007/s00296-018-4144-8
UR  - http://hdl.handle.net/10668/12870
T2  - Rheumatology international
AB  - Although several randomized clinical trials and observational studies have evaluated the effectiveness, safety and drug survival of etanercept (ETN) in the treatment of psoriatic arthritis (PsA), long-term data regarding these aspects are currently...
LA  - en
KW  - Arthritis
KW  - Etanercept
KW  - Psoriasis
KW  - Psoriatic
KW  - Survival
KW  - TNF-α blockers
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antirheumatic Agents
KW  - Arthritis, Psoriatic
KW  - Drug Administration Schedule
KW  - Etanercept
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Practice Patterns, Physicians'
KW  - Retrospective Studies
KW  - Spain
KW  - Tertiary Care Centers
KW  - Time Factors
KW  - Treatment Outcome
TI  - Long-term etanercept survival in patients with psoriatic arthritis: a multicenter retrospective analysis in daily clinical practice in Spain.
TY  - research article
VL  - 38
ER  -